Article Details

Budesonide (BUD) Market to Get a New Boost |AstraZeneca, Cosmo Pharmaceuticals, Teva, Mylan

Retrieved on: 2022-04-15 11:48:46

Tags for this article:

Click the tags to see associated articles and topics

Budesonide (BUD) Market to Get a New Boost |AstraZeneca, Cosmo Pharmaceuticals, Teva, Mylan. View article details on hiswai:

Excerpt

AstraZeneca, Cosmo Pharmaceuticals, Teva, Mylan, Sandoz, Dr. Falk Pharma, Chiesi Farmaceutici S.p.A, Orion Corporation, Cipla, Synmosa Biopharma ...

Article found on: politicalbeef.co.uk

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up